MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
+0.4%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$549M
AUM Growth
+$549M
(-15%)
Cap. Flow
-$19.3M
Cap. Flow
% of AUM
-3.52%
Top 10 Holdings %
Top 10 Hldgs %
73.13%
Holding
35
New
2
Increased
2
Reduced
22
Closed
2
Top Buys
| 1 |
MEI Pharma
MEIP
|
$33M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$2.92M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
$2.31M |
| 4 |
Verastem
VSTM
|
$916K |
Top Sells
| 1 |
ITOS
iTeos Therapeutics
ITOS
|
$12.2M |
| 2 |
LHDX
Lucira Health, Inc. Common Stock
LHDX
|
$4.39M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
$1.37M |
| 4 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$824K |
| 5 |
Cytokinetics
CYTK
|
$685K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Mirum Pharmaceuticals
MIRM
$3.75B
| $4.77M | 0.87% |
298,852
-9,680
| -3% | -$154K |
|
27
Axsome Therapeutics
AXSM
$6.09B
| $3.91M | 0.71% |
103,405
-6,750
| -6% | -$255K |
|
28
Revolution Medicines
RVMD
$7.43B
| $3.68M | 0.67% |
146,041
-3,959
| -3% | -$99.7K |
|
|
AVDL
29
Avadel Pharmaceuticals
AVDL
$1.42B
| $3.03M | 0.55% |
375,326
-24,674
| -6% | -$199K |
|
|
30
Acadia Pharmaceuticals
ACAD
$4.34B
| $2.92M | 0.53% |
+125,000
| New | +$2.92M |
|
|
TECX
31
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $2.49M | 0.45% |
647,918
-213,940
| -25% | -$824K |
|
|
INZY
32
DELISTED
Inozyme Pharma
INZY
| $2.06M | 0.38% |
302,615
-18,109
| -6% | -$124K |
|
33
Black Diamond Therapeutics
BDTX
$164M
| $1.28M | 0.23% |
239,888
-8,618
| -3% | -$45.9K |
|
|
LHDX
34
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| – | – |
-578,114
| Closed | -$4.39M |
|